Page last updated: 2024-09-05

enzastaurin and Hypereosinophilic Syndrome

enzastaurin has been researched along with Hypereosinophilic Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Brümmendorf, TH; Chatain, N; Feldberg, K; Gezer, D; Herrmann, O; Jawhar, M; Koschmieder, S; Ma, G; Reiter, A; Schemionek, M	1

Other Studies

1 other study(ies) available for enzastaurin and Hypereosinophilic Syndrome

Article	Year
LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophilia. Molecular carcinogenesis, 2020, Volume: 59, Issue:1 Topics: Adult; Aged; Cell Line; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Female; Humans; Hypereosinophilic Syndrome; Indoles; Male; Mechanistic Target of Rapamycin Complex 2; Microfilament Proteins; Middle Aged; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt	2020

Article

Year

LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophilia.

Molecular carcinogenesis, 2020, Volume: 59, Issue:1

Topics: Adult; Aged; Cell Line; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Female; Humans; Hypereosinophilic Syndrome; Indoles; Male; Mechanistic Target of Rapamycin Complex 2; Microfilament Proteins; Middle Aged; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt

2020